Article

Exercise improves body fat, lean mass, and bone mass in breast cancer survivors

Yale School of Medicine, New Haven, Connecticut, USA.
Obesity (Impact Factor: 4.39). 09/2009; 17(8):1534-41. DOI: 10.1038/oby.2009.18
Source: PubMed

ABSTRACT Given the negative effects of a breast cancer diagnosis and its treatments on body weight and bone mass, we investigated the effects of a 6-month randomized controlled aerobic exercise intervention vs. usual care on body composition in breast cancer survivors. Secondary aims were to examine the effects stratified by important prognostic and physiologic variables. Seventy-five physically inactive postmenopausal breast cancer survivors were recruited through the Yale-New Haven Hospital Tumor Registry and randomly assigned to an exercise (n = 37) or usual care (n = 38) group. The exercise group participated in 150 min/week of supervised gym- and home-based moderate-intensity aerobic exercise. The usual care group was instructed to maintain their current physical activity level. Body composition was assessed at baseline and 6-months through dual-energy X-ray absorptiometry (DXA) by one radiologist blinded to the intervention group of the participants. On an average, exercisers increased moderate-intensity aerobic exercise by 129 min/week over and above baseline levels compared with 45 min/week among usual care participants (P < 0.001). Exercisers experienced decreases in percent body fat (P = 0.0022) and increases in lean mass (P = 0.047) compared with increases in body fat and decreases in lean mass in usual care participants. Bone mineral density (BMD) was also maintained among exercisers compared with a loss among usual care participants (P = 0.043). In summary, moderate-intensity aerobic exercise, such as brisk walking, produces favorable changes in body composition that may improve breast cancer prognosis.

Download full-text

Full-text

Available from: Susan T Mayne, Jul 18, 2014
0 Followers
 · 
165 Views
  • Source
    • "This weight gain was often described as a decrease in lean body mass with a concurrent increase in body fat, defined as sarcopenic obesity (Demark- Wahnefried et al., 2008; Demark-Wahnefried et al., 2001; Irwin et al., 2009). Weight gain was often a source of distress and a risk for the development of secondary tumors as well as chronic illnesses such as cardiovascular disease, diabetes, and hypertension (Aldana et al., 2005; Demark-Wahnefried et al., 2000; Visovsky, 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this secondary analysis was to describe the extent to which women with breast cancer, who participated in a randomized control trial on exercise, adopted American Cancer Society (ACS) guidelines for healthy lifestyle behaviors. Women in the study exercised during cancer treatment and for 6 months after completion of treatment. The sample included 106 women, average age 50.7 years (SD = 9.6). Adherence to guidelines for 5 servings of fruits and vegetables ranged from 36% (n = 28) to 39% (n = 36). Adherence with alcohol consumption guidelines was 71% (n = 28) to 83% (n = 30). Adherence with meeting a healthy weight ranged from 52% (n = 33) to 61% (n = 31). Adherence with physical activity guidelines ranged from 13% (n = 30) to 31% (n = 35). Alcohol and healthy weight guidelines were followed by more than half of the participants, but physical activity and dietary guidelines were followed by far fewer women. Further prospective clinical studies are indicated to determine whether interventions are effective in producing a healthy lifestyle in cancer survivors.
    Clinical Nursing Research 10/2014; DOI:10.1177/1054773814553298 · 0.87 Impact Factor
  • Source
    • "Women's motivation to present an attractive physique might lead them to use strategies to mitigate the physical changes that occur following treatment for breast cancer and that can bring them closer to the ideal female body. Physical activity is likely one such strategy because it has been shown to help women lose weight and body fat, avoid weight gain, and build muscle tone (Cadmus et al., 2009; Irwin et al., 2009). Accordingly, women might engage in physical activity to improve their appearances and shape the impressions formed by others. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: In the current study, we (a) describe naturally occurring changes in self-presentation processes (i.e., impression motivation, impression construction) and moderate-to-vigorous intensity physical activity (MVPA) over a period of 6 months among women who were treated for breast cancer; (b) evaluate the associations of cancer-specific factors with self-presentation processes and MVPA; and (c) examine the within- and between-person associations of self-presentation processes with MVPA. Method: For this prospective longitudinal study, women (n = 128; Mage = 55.14 years) completed questionnaires posttreatment for breast cancer (Mtime since treatment = 3.96 months), as well as 3 and 6 months later. Results: Based on the findings of the multilevel analysis, self-presentation processes remained stable over time, whereas MVPA levels changed over time (Blinear = 6.11, SE = 2.44, Bquadratic = -3.41, SE = 1.23). Radiotherapy was related to impression motivation (B = -.40, SE = .19) and impression construction (B = -.45, SE = .15), and chemotherapy was related to impression motivation (B = .31, SE = .15). Impression motivation was associated with MVPA at the between-person level (γ01 = 5.72, SE = 1.22), and impression construction was associated with MVPA at the between- and within-person levels (γ01 = 3.45, SE = 1.49; γ10 = 3.67, SE = 1.66). Conclusions: This study provides insight into the patterns of self-presentation processes and MVPA during early cancer survivorship, as well as the associations between these constructs at the within- and between-person levels. Based on these findings, more research is needed to determine whether self-presentation processes should be conceptualized as state or trait characteristics or as having both components, and extend the self-presentation framework to incorporate additional explanatory variables as this might provide a more complete explanation of MVPA. (PsycINFO Database Record (c) 2012 APA, all rights reserved).
    Health Psychology 03/2014; 33:205-213. DOI:10.1037/a0030414 · 3.95 Impact Factor
  • Source
    • "In addition to the measurement of bone and the diagnosis of osteoporosis, dual-energy X-ray absorptiometry (DXA) has become an established technique for the measurement of body composition in both research and clinical practise. DXA has become a common primary outcome for investigations of the effects of interventions or disease on body composition (Irwin et al., 2009) and the extent of obesity in patients (Uusi-Rasi et al., 2009) In addition, more recent models of DXA are able to quantify android and gynoid fat accumulation, and have been used for investigations of cardiovascular risk (Berends et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In vivo precision for body composition measurements using dual energy X-ray absorptiometry (DXA; GE Lunar iDXA, GE Healthcare, Bucks, UK) was evaluated in 52 men and women, aged 34.8 (s.d. 8.4; range 20.1-50.5) years, body mass index (25.8 kg/m(2); range 16.7-42.7 kg/m(2)). Two consecutive total body scans (with re-positioning) were conducted. Precision was excellent for all measurements, particularly for total body bone mineral content and lean tissue mass (root mean square 0.015 and 0.244 kg; coefficients of variation (CV) 0.6 and 0.5%, respectively). Precision error was CV 0.82% for total fat mass and 0.86% for percentage fat. Precision was better for gynoid (root mean square 0.397 kg; CV 0.96%) than for android fat distribution (root mean square 0.780 kg, CV 2.32%). There was good agreement between consecutive measurements for all measurements (slope (s.e.) 0.993-1.002; all R(2) = 0.99). The Lunar iDXA provided excellent precision for total body composition measurements. Research into the effect of body size on the precision of DXA body fat distribution measurements is required.
    European journal of clinical nutrition 01/2011; 65(1):140-2. DOI:10.1038/ejcn.2010.190 · 2.95 Impact Factor
Show more